{"name":"STCube, Inc.","slug":"stcube-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE8wUGEwTTFDT01xMDVBaEpvb3M5NU1sTDRGN2NlQ0dUYWg0OVMydU5kdTdKQUJHLUpwcUpRU082MDlMdzh2VXVZVG14QzA5Yk5FS1FOYU9MV09jRDJRLWdaRVk2cm0xQ0RjdnZHZXJR0gFyQVVfeXFMTVF0emwxeWotV0lrQ2FNMkVYTEpJeVVLMzFFaEpwcmxKVllreVIydVBKMnF1UjZPckZKV3N0cVh6Y0FScnUzY0xSM2t0c0JyUk43VXA0dGIwRmpOS2tnYmxFRnRmV2xfRjEwNDJwLXN1ckFn?oc=5","date":"2026-01-12","type":"trial","source":"koreabiomed.com","summary":"STCube presents ASCO GI data on biomarker for colorectal cancer therapy - koreabiomed.com","headline":"STCube presents ASCO GI data on biomarker for colorectal cancer therapy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE44OWgxX0hGQTlXRjJlVEJJN3ZzRk9GOW8tUjNvUHhuelp2aDkxbG44bEdXQmVmMHRZc0NTVGZpbTJSc0dNUjVaZTZfRkNPSlNsVVhUdF9veTBaUGNsMWRWSEtwMUJMSGhlWE1BWdIBcEFVX3lxTFAyc2ZRU3lxcGQyRE5WaWZ0ckFrUTdudzlfQ1JWMHBJRG12Ul9jeVRvQ0hzb3YtNnNDYTRuNkNKZURzVmtCVzc3RVJwalZlWXVDZVVfajVXS0FZUTFHTElUYnY5VkgyWVJMYnd4X1gteHg?oc=5","date":"2025-05-29","type":"pipeline","source":"더바이오","summary":"Nelmastobart emerges as a truly biomarker-based next-generation immune checkpoint inhibitor - 더바이오","headline":"Nelmastobart emerges as a truly biomarker-based next-generation immune checkpoint inhibitor - 더바이오","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBNTnNLbXg1dGp2el9FOFI5MjBNVmJwLVZlUDBoYVRySlU5TjRueEZzazd3UDdGdWdZTnV6U29pM2pvVmNXOUd1NkZXZVNKNUJQVEl1Y3JNVGZ3cENUQ05mekhkV1RUNndUd0JHLTFR0gFyQVVfeXFMTm5vWnI2QTUyemFaOXRRVVdTTzVFdEhCc29hWVZOUnJTOTZpb3hOQ2VJN2ozZ0NKTE40TEIxaEJ0c3lNTDdNZXAxdlR3N3YxMWZhTDdJLUFCMXh6WV9GanhEQzFjMm12cWQ1MHBvMWpLN1pR?oc=5","date":"2025-04-03","type":"pipeline","source":"koreabiomed.com","summary":"Korean pharma and biotech to unveil innovative cancer research at AACR 2025 - koreabiomed.com","headline":"Korean pharma and biotech to unveil innovative cancer research at AACR 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE9fUzZWQkEyRld0bjctM3JFejJGQ2swdnQ3TGktcmptMDd2NU5pbWJtSHFXc3d6NURoOUx0c0oxUVVCRUdFb1NpY096QU9XZTBKUHFLMjBPNHhsNzJHWjZVTjhhejVmbi01cm5oV2l30gFyQVVfeXFMUHltS0l4N2x3RjlFN2xncEcxSVRvY1NSaWVPd3JTRkIwV25aWXkzcGZuSllxcE0zcTBQV3ByTjlWdWQtaUgxbUg3MklWQzZPamhFUUV3dEd3SENUMDExcnM0QnBWZVA0VVNtbGRlV05TdEhB?oc=5","date":"2025-03-21","type":"regulatory","source":"koreabiomed.com","summary":"STCube receives IND approval for nelmastobart in metastatic colorectal cancer in Korea - koreabiomed.com","headline":"STCube receives IND approval for nelmastobart in metastatic colorectal cancer in Korea","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBhTkg4QUxXdjIwTVlVTF9QeXpiYktodEg0QzlwSlV0OUFjSDh3RDdIT1NMOU5Id0xNN1htN0JDZlZIa2tlb05FaEV0Z0xIMFZqT2JCajlVYnNJc19HaGZhcUE2VGFaUDVvd2JhMVN30gFyQVVfeXFMTllVR1RHcHdaQm5NOU05Nk83RldKOTNGVTJLeElNV0xIY1FiZTdVeVFOM1AzVktHOE02VldlOWxWWDk5OUU5U0dxS0hGbmpiQW1oNGNVN0dwZ2R4ZFdoOTU4dFdxUHh1RG9JQ1ZTN3A4Q1FR?oc=5","date":"2024-10-31","type":"pipeline","source":"koreabiomed.com","summary":"Korean biotech companies to present latest cancer immunotherapies at SITC 2024 - koreabiomed.com","headline":"Korean biotech companies to present latest cancer immunotherapies at SITC 2024","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}